HAYA Therapeutics

Lausanne, Switzerland · Founded 2017 · Privately Held (backing)

Operator of a precision therapeutics company intended to discover and develop tissue and cell-selective genomic medicines for fibrotic diseases. HAYA Therapeutics is based in Lausanne, Switzerland and was founded in 2017. Its last reported valuation was $115 million in Apr 2025. It has raised $101 million.

Last reported valuation
$115.5M
Oct 2026
Priced at
—
Total raised
$101.0M
Last round
—

Who backs HAYA Therapeutics?

18 investors
InvestorType
MassChallenge—
Venture KickOther
Alexandria Venture InvestmentsOther
Earlybird Venture CapitalVenture capital
Sofinnova PartnersVenture capital
Schroders CapitalOther
Athos CapitalVenture capital
Viva BioInnovatorOther
Numan Wealth PartnersFamily office
4See Ventures—
+ 8 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

HAYA Therapeutics investors

18 investors are on record for HAYA Therapeutics, including MassChallenge, Venture Kick, Alexandria Venture Investments and Earlybird Venture Capital.

Free account
More of HAYA Therapeutics with a free account
  • ·The complete investor list: 18 names
  • ·Watch HAYA Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 18 firms already write checks for companies like HAYA Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View